Morgan Stanley analyst Connor Lynagh maintains Liberty Energy (NYSE:LBRT) with a Overweight and raises the price target from $21 to $22.
Oncocyte VitaGraft Kidney Study Results Published In The New England Journal Of Medicine
Late-breaking presentation of data at American Transplant Congress on Monday, June 3Data show potential to monitor for therapeutic efficacy and recurrencePotential repeat testing opportunities with claims
